Bio-physical and theoretical investigations on Pt(II)-pyridine based complexes with relevant bio-molecules for the development of potent anticancer drug candidates

Rituparna Bhaduri,Sankar Ch. Moi
DOI: https://doi.org/10.1016/j.molstruc.2024.138261
IF: 3.841
2024-04-10
Journal of Molecular Structure
Abstract:Pyridine-derived Pt(II) complexes Pt1 , [Pt(NMPA)Cl 2 ]; Pt2 , [Pt(NMPA)(H 2 O)](NO 3 ) 2 ; Pt3 , [Pt(NMPA)(DL-pen)](NO 3 ); Pt4 , [Pt(NMPA)(DL‐meth)](NO 3 ) 2 ; Pt5 , [Pt(NMPA)(OX)]; and Pt6 , [Pt(NMPA)(CBDCA)] (where, NMPA = N -methyl-2-(2′-pyridyl)-ethylamine; DL-pen = DL-penicillamine; DL‐meth = DL-methionine; OX = oxalate; CBDCA = 1,1-cyclobutanedicarboxylate) were synthesized and characterized by elemental microanalysis and multi-spectroscopic methods. The electronic structures, molecular electrostatic potential, and natural bond orbital analysis, spectral simulations were studied by DFT and TD-DFT methods. Bio-interaction with CT-DNA was investigated with UV–Vis, competitive fluorescence titration, and viscometric measurements. BSA-complex interactions were probed by spectrophotometric methods. The experimental binding studies with DNA and BSA were strongly validated by molecular docking. ADMET and PASS parameters provided a clear theoretical interpretation of the pharmacokinetic and anticarcinogenic behavior of the synthesized drug candidates. The bio-efficacy and selectivity of the complexes was screened against A549 and HCT116 cell lines by in vitro cytotoxicity assay. A remarkable non-toxic effect on non-tumorigenic cells (HEK-293) was deduced by the NBT assay.
chemistry, physical
What problem does this paper attempt to address?